Skip to main content

Facts and myths about the microbiome

Advertisement

At a press conference organised by the German Society for Gastroenterology, Digestive and Metabolic Diseases, Prof. Dr Thomas Frieling, Head of Medical Clinic II at Helions Klinikum Krefeld (Germany), spoke about the microbiome and the current state of knowledge on the subject. He also addressed myths and purported health-promoting measures.

The gastrointestinal tract is the longest organ in the body, and every part of it is colonised by bacteria. The collection of microorganisms (microbiota) living in a specific environment, such as the gastrointestinal tract, is called the microbiome.

According to current scientific understanding, the gastrointestinal microbiome is of enormous importance to health, for example for the immune system. However, this ‘bacterial flora’ in the gut also plays a significant role in regulating many bodily functions (e.g. digestive functions) and in diseases (e.g. chronic inflammatory bowel diseases, irritable bowel syndrome and disorders of the gut-brain axis).

Which bacteria inhabit the gut?

Large-scale analyses, known as metagenomic analyses, have identified nearly 2,000 different gut bacteria worldwide. However, not all of these are present in equal proportions in our gastrointestinal microbiome. Some phyla, such as Bacteroidetes and Firmicutes, are dominant. Others, such as Actinobacteria, Proteobacteria and Verrucomicrobia, are found in smaller numbers. “It appears that individual groups play a significant role in the stability of the gastrointestinal microbiome,” explained Frieling.

What is a healthy gastrointestinal microbiome?

Although there is a great deal of scientific research, it is still not possible to define the ‘healthy’ microbiome in the human gut. “There are still major gaps in our knowledge. Added to this are many myths containing incorrect information about the gastrointestinal microbiome,” Frieling clarified. For instance, according to recent scientific studies, fundamental assumptions about the mass of the microbiome are incorrect. Contrary to what was long assumed, the microbiome in the gastrointestinal tract does not weigh 1.5 to two kilograms, but ‘only’ around 100 grams (the total bacterial mass in the human body is around 200 grams). “The claim that the number of bacteria in our bodies exceeds the number of human body cells by a factor of ten has also been shown to be unfounded. We now know that the ratio of bacterial cells to body cells is roughly equal,” said Frieling.

“Debunking myths is not intended to diminish the importance of the microbiome, but to show that many fundamental aspects have yet to be researched.”

Prof. Dr Thomas Frieling

At present, we also know too little about the ‘correct’ composition of bacteria. “The reasons for around 80 per cent of the important bacterial diversity in the gastrointestinal tract are still completely unclear,” Frieling explained. Consequently, it is not yet possible to influence the human microbiome in a way that promotes health. Diet is likely to be a key factor in influencing the microbiome. It also plays a significant role in energy balance – that is, the relationship between energy intake and expenditure. However, our understanding of this is still too patchy to allow us to make definitive statements.

What is the value of bacterial analyses of stool samples?

Another field that remains under-researched and is therefore not scientifically substantiated is bacterial testing. The search for pathogenic (disease-causing) agents in stool (e.g. salmonella, rotaviruses) is successfully used to diagnose diarrhoeal diseases. The situation is different when it comes to analysing the individual microbiome: “To put it bluntly, I would describe stool tests for analysing the gut microbiome as ‘voodoo medicine’. Clinically, these tests are of no significance whatsoever,” Frieling clarified. The time frame alone – from sample collection to laboratory analysis, which takes around one to three days – renders such stool tests useless. This is because the bacteria in the stool continue to grow during this time, meaning the samples are not representative of the current situation in the gut.

The results of microbiome analyses in stool are unclear even in scientific studies. The reason for this is the insufficient standardisation of stool characteristics – in other words, the values are not standardised and are therefore not comparable. The microbiome and its bacterial diversity are determined by the frequency of bowel movements, the volume, the texture/consistency and the water content of the stools. This is described using the so-called Bristol Stool Form Scale. Furthermore, all these factors are linked to the time it takes for food to pass through the gut (gut transit time). However, most studies do not take any of this into account.

There is also still too little knowledge about the bacteria in the intestinal mucosa (mucosa-associated bacteria). On the one hand, this mucosa absorbs water and nutrients from food; on the other, it forms a protective layer against pathogens. “We cannot measure the bacteria at work here in the same way as we can in the stool,” explained Frieling. “Yet this is probably the crucial part of the microbiome that interacts with the immune and nervous systems via the mucosa. The clinical relevance of many of the findings currently known is therefore overestimated!”

What role does the gut microbiome play in diseases?

Just as there are still major gaps in our knowledge regarding the composition of the gastrointestinal microbiome, there are also gaps regarding the microbiome’s relevance to diseases. As Frieling reported, there have already been impressive results in animal studies. By transferring faeces from one animal to another (faecal microbiota transfer), diseases could be influenced or even triggered. In this context, there is a wealth of data on the transmission of rheumatoid arthritis and diabetes mellitus via gut bacteria from sick to healthy animals. Research has also been conducted into neurological disorders and irritable bowel syndrome. However, Frieling clarified that many of the findings stem from basic scientific research and cannot be directly applied to humans. Whilst there are impressive results from animal studies on faecal transplantation, this procedure is currently established and approved in humans only for Clostridium difficile infection. “Although a reduction in microbiome diversity can be demonstrated in most diseases, a reliable characterisation of typical disease-causing bacteria is not possible due to the heterogeneous and insufficient body of research.”

What role does the gut microbiome play in irritable bowel syndrome?

The microbiome also plays a major role in irritable bowel syndrome. As with almost all diseases, it has been found here too that the variety of bacteria – their diversity – is reduced, according to Frieling. However, it has not yet been possible to identify enough bacteria that are responsible for the condition. So, attempting to influence the condition therapeutically via the microbiome would amount to a trial-and-error approach. One would therefore have to try out certain things. “The use of probiotics, for example, is entirely justified, but one cannot favour one probiotic over another. The IBS guidelines contain recommendations for specific probiotics based on the predominant symptoms. However, the evidence on this is so limited that, in clinical practice, one always has to try out what works.”

Unlike in the case of Clostridium difficile colitis, faecal transplantation is not permitted for irritable bowel syndrome outside of clinical trials. Scientific studies do, however, show benefits for subgroups of IBS patients. It is possible that it is not the bacteria themselves, but components of the intestinal fluid (including bacteriophages) that are responsible for the health-promoting effects.

The gastrointestinal microbiome plays an enormous role in gastrointestinal disorders, including irritable bowel syndrome. However, apart from reduced diversity, no individual bacteria have yet been identified that could be used to treat these conditions, Frieling concluded.

  • Author

    Gernot Hofer

More on this topic
Hormones

Low testosterone in men: symptoms, causes and treatment

Fatigue, a reduced sex drive, and a lack of energy: these symptoms can have many causes. One possible explanation is a testosterone deficiency. However, it is not possible to determine whether testosterone levels are actually too low based solely on the symptoms or on a single blood test result.

Men's health
Men's health

PSA level: What does it mean, and when is it too high?




The PSA level is one of the best-known laboratory test results relating to the prostate. Many men come across it for the first time during a screening examination or when having symptoms investigated. An abnormal result often raises questions: Is this already a sign of prostate cancer? What levels are considered normal?

Prostate
Pollen allergy

The right diet for hay fever

Anyone suffering from hay fever should pay particular attention to their diet so as not to make the symptoms any worse.

Nutrition
Urology

Prostate health: What men need to know

The prostate is a gland in a man’s body that is only the size of a chestnut, but it plays a crucial role in well-being, urinary function and male sexuality. Benign enlargement and prostate cancer become more common in older age.

Prostate